SCHEMBL3529974

SCHEMBL3529974

O=C(O)NCCc1ccc(Cl)cc1Cl

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.67
CNR1 P21554 2/20 0.66
PLAAT3 P53816 1/20 0.60
PLAAT5 Q96KN8 1/20 0.60
PLAAT2 Q9NWW9 1/20 0.60
PLAAT4 Q9UL19 1/20 0.60
KMT2A Q03164 2/20 0.56
ALDH1A1 P00352 3/20 0.55
TAAR1 Q96RJ0 1/20 0.55
TRPV1 Q8NER1 1/20 0.54
KDM4E B2RXH2 1/20 0.54
METAP2 P50579 4/20 0.54
MEN1 O00255 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
LMNA P02545 1/20 0.52
HTT P42858 1/20 0.51
METAP1 P53582 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28753564 0.85 HPGD (0.50) HPGDCNR1PLAAT3PLAAT5PLAAT2
SCHEMBL4038474 0.85 HPGD (0.69) HPGDCNR1PLAAT3PLAAT5PLAAT2
SCHEMBL19376791 0.83 HPGD (0.49) HPGDCNR1PLAAT3PLAAT5PLAAT2
SCHEMBL7405242 0.83 HPGD (0.49) HPGDCNR1PLAAT3PLAAT5PLAAT2
SCHEMBL27611366 0.83 HPGD (0.49) HPGDCNR1PLAAT3PLAAT5PLAAT2
SCHEMBL697972 0.82 ALDH1A1 (0.63) CNR1ALDH1A1TDP1LMNA
SCHEMBL5654926 0.82 HPGD (0.48) HPGDCNR1PLAAT3PLAAT5PLAAT2
SCHEMBL13034051 0.82 CNR1 (0.57) HPGDCNR1PLAAT3PLAAT5PLAAT2
SCHEMBL17330349 0.81 HPGD (0.47) HPGDCNR1PLAAT3PLAAT5PLAAT2
SCHEMBL16795265 0.81 HPGD (0.52) HPGDCNR1PLAAT3PLAAT5PLAAT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016029146-A1 SPECIFIC INHIBITORS OF METHIONYL-TRNA SYNTHETASE UNIVERSITY OF WASHINGTON (US) 2016-02-25 WO claimed
US-7825149-B2 Substituted imidazoles PFIZER LIMITED (GB) 2010-11-02 US disclosed
US-20090312326-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2009-12-17 US disclosed
US-7592362-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-09-22 US disclosed
US-7547718-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-16 US disclosed
US-7544706-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-09 US disclosed
US-20080125473-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-29 US disclosed
US-20080119536-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-22 US disclosed
US-20070167506-A1 SUBSTITUTED IMIDAZOLES PFIZER INC. (US) 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125473-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 HPGD 2124/4885CNR1 1586/4885PLAAT3 4504/4885
US-20090312326-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 HPGD 2124/4885CNR1 1586/4885PLAAT3 4504/4885
US-20070167506-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 HPGD 2124/4885CNR1 1586/4885PLAAT3 4504/4885
US-20080119536-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 HPGD 2124/4885CNR1 1586/4885PLAAT3 4504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.